ZEMA Pharma Consulting ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About ZEMA Pharma Consulting ApS
ZEMA Pharma Consulting ApS (CVR number: 42680427) is a company from GENTOFTE. The company recorded a gross profit of 102.2 kDKK in 2025. The operating profit was -246.2 kDKK, while net earnings were -216.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was -30.5 %, which can be considered poor and Return on Equity (ROE) was -46.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 44.9 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. ZEMA Pharma Consulting ApS's liquidity measured by quick ratio was 1.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Volume | ||||
| Net sales | ||||
| Gross profit | 1 146.08 | 1 472.11 | 130.75 | 102.23 |
| EBIT | 1 101.61 | 970.91 | - 389.21 | - 246.19 |
| Net earnings | 789.56 | 812.35 | - 281.63 | - 216.74 |
| Shareholders equity total | 829.56 | 852.91 | 571.29 | 354.54 |
| Balance sheet total (assets) | 1 187.22 | 1 586.54 | 630.45 | 788.91 |
| Net debt | -1 187.22 | -1 580.82 | - 585.31 | - 330.22 |
| Profitability | ||||
| EBIT-% | ||||
| ROA | 93.5 % | 75.2 % | -25.1 % | -30.5 % |
| ROE | 95.2 % | 96.6 % | -39.5 % | -46.8 % |
| ROI | 133.8 % | 124.0 % | -39.0 % | -46.8 % |
| Economic value added (EVA) | 858.98 | 715.64 | - 432.07 | - 274.90 |
| Solvency | ||||
| Equity ratio | 69.9 % | 53.8 % | 90.6 % | 44.9 % |
| Gearing | ||||
| Relative net indebtedness % | ||||
| Liquidity | ||||
| Quick ratio | 3.3 | 2.2 | 10.7 | 1.8 |
| Current ratio | 3.3 | 2.2 | 10.7 | 1.8 |
| Cash and cash equivalents | 1 187.22 | 1 580.82 | 585.31 | 330.22 |
| Capital use efficiency | ||||
| Trade debtors turnover (days) | ||||
| Net working capital % | ||||
| Credit risk | ||||
| Credit rating | BB | BBB | BB | BBB |
Variable visualization
Roles
Companies in the same industry
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.